Ventilator-associated pneumonia: Difference between revisions
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
==Treatment== | ==Treatment== | ||
[[Ventilator-associated pneumonia clinical strategy|Recommendations for clinical strategy]] | [[Ventilator-associated pneumonia medical therapy|Medical Therapy]] | [[Ventilator-associated pneumonia prevention|Prevention]] | [[Ventilator-associated pneumonia clinical strategy|Recommendations for clinical strategy]] | [[Ventilator-associated pneumonia medical therapy|Medical Therapy]] | [[Ventilator-associated pneumonia prevention|Prevention]] | [[Hospital-acquired pneumonia response to therapy|Assessing response to therapy]] | ||
[[Category:Diseaase]] | [[Category:Diseaase]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
Revision as of 20:03, 13 September 2012
Template:Ventilator-associated pneumonia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differential diagnosis
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray
Treatment
Recommendations for clinical strategy | Medical Therapy | Prevention | Assessing response to therapy